The Women’s Health Investment Summit is a curated, high-signal investor gathering designed to scale innovations in global women’s and children’s health. Presented by Cross Border Impact Ventures and MaRS Discovery District, the summit unites LPs, VCs, medtech founders, corporate strategics and global health experts to unlock the capital and commercialization pathways essential for building category-defining companies.
Christina Yeh, Vice President, Programs & Strategic Partnerships, and Garima Ghale, Associate Director, Programs & Strategic Partnerships at OBIO®, will attend the Summit.
